Trial
NCT01984268
ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Mallinckrodt
Condition
Rheumatoid Arthritis
Intervention
ACTHAR
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-15